GlassScriptPhysician profile
Caesar A Ricci
NPI 1417268418
$27,261.84
in general payments reported to CMS, 2019-2025
28 companies · $7,563 in 2025
The $7,563 reported for 2025 was more than what 93% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $940 · 2020: $80.27 · 2021: $1,626 · 2022: $9,229 · 2023: $4,590 · 2024: $3,233 · 2025: $7,563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,200 · Food and Beverage: $4,693 · Education: $3,015 · Travel and Lodging: $1,179 · Entertainment: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,200.00 |
| Food and Beverage | $4,692.87 |
| Education | $3,015.00 |
| Travel and Lodging | $1,178.94 |
| Entertainment | $299.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,326.51 | 2022-2023 | Davinci Xi, Da Vinci Surgical System |
| Vericel Corporation | $6,939.04 | 2023-2025 | Nexobrid, Epicel (Cultured Epidermal Autografts) |
| Kerecis Limited | $2,866.29 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Avita Medical Americas, LLC | $2,000.00 | 2024 | |
| Polynovo North America LLC | $675.63 | 2019-2025 | Novosorb Btm |
| Argentum Medical | $452.84 | 2021-2025 | |
| Smith+Nephew, INC. | $429.60 | 2022-2025 | Collagenase Santyl, Versajet, Oasis |
| Integra Lifesciences Corporation | $402.16 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tei Biosciences INC | $326.84 | 2019 | |
| Polymedics Innovations INC. | $254.46 | 2022-2025 | |
| Davol INC. | $242.97 | 2023-2025 | Phasix Mesh |
| Prytime Medical Devices, INC. | $200.70 | 2019 | |
| Zimmer Biomet Holdings, INC. | $197.37 | 2019-2020 | |
| Access Pro Medical, LLC | $174.51 | 2022-2025 | Matriderm, Matriderm |
| Ovik Health, LLC | $141.01 | 2022-2025 | Assist Silver |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $137.83 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Ethicon US, LLC | $119.78 | 2022-2024 | Ethicon, Echelon Flex, Stratafix |
| Musculoskeletal Transplant Foundation INC. | $79.98 | 2024-2025 | |
| Mimedx Group, INC. | $62.59 | 2024-2025 | |
| Aroa Biosurgery Incorporated | $62.57 | 2025 | |
| Acera Surgical, INC. | $61.02 | 2025 | Restrata Wound Matrix |
| W. L. Gore & Associates, INC. | $19.41 | 2022 | |
| Convatec INC. | $19.01 | 2023 | |
| Tela Bio, INC. | $18.21 | 2022 | |
| Teleflex LLC | $15.92 | 2022 | |
| Kci USA, INC. | $15.00 | 2023 | V.A.C.Ulta |
| Deroyal Industries, INC. | $14.75 | 2022 | |
| Checkpoint Surgical, INC | $5.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caesar Ricci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.